Product Name:4-(piperidin-4-yl)benzoic acid hydrochloride

IUPAC Name:4-(piperidin-4-yl)benzoic acid hydrochloride

CAS:149353-84-4
Molecular Formula:C12H16ClNO2
Purity:95%
Catalog Number:CM127530
Molecular Weight:241.72

Packing Unit Available Stock Price($) Quantity
CM127530-5g in stock IJƓǵ
CM127530-10g in stock ƥƿŹ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:149353-84-4
Molecular Formula:C12H16ClNO2
Melting Point:-
Smiles Code:O=C(O)C1=CC=C(C2CCNCC2)C=C1.[H]Cl
Density:
Catalog Number:CM127530
Molecular Weight:241.72
Boiling Point:399.7°C at 760 mmHg
MDL No:MFCD08460726
Storage:Store at room temperature.

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Tasurgratinib
Eisai announced that it has obtained manufacturing and marketing approval for fibroblast growth factor receptor (FGFR) selective tyrosine kinase inhibitor ‘TASFYGO® Tablets 35mg’ (tasurgratinib succinate) in Japan for the treatment of patients with unresectable biliary tract cancer with FGFR2 gene fusions or rearrangements that progressed after cancer chemotherapy. In Japan, it has received orphan drug designation from the Ministry of Health, Labour and Welfare (MHLW), and the marketing authorization application was submitted in December 2023. TASFYGO is an orally available novel tyrosine kinase inhibitor that demonstrates selective inhibitory activity against fibroblast growth factor receptors (FGFR) FGFR1, FGFR2 and FGFR3.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products